GSK
Tuesday, June 04, 2024
Multiline Global Biopharma
Company Presentation Theater 2
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We focus on science of the immune system and advanced technologies, investing in 4 core therapeutic areas (Infectious Diseases, HIV, Respiratory/ Immunology and Oncology) to impact health at scale.
.png)
Company Website:
http://www.gsk.com
Lead Product in Development:
Shingrix
Trelegy Ellipta
Dovato
Nucala
Triumeq
Exchange
NYSE
London
Ticker
GSK
Company HQ City
Brentford
Company HQ State
Middlesex
Company HQ Country
United Kingdom
CEO/Top Company Official
Emma Walmsley
Development Phase of Primary Product
Multiple Products in Market
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())